Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2003
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1287827A1 Immunopotentiator
03/05/2003EP1287364A2 Diagnostics and therapeutics for macular degeneration-related disorders
03/05/2003EP1287363A2 Modulation of t-cell receptor interactions
03/05/2003EP1287147A2 Immunotoxin fusion proteins and means for expression thereof
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287140A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287120A2 Human circulating dendritic cell compositions and methods
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286703A2 Methods and compounds for controlled release of recombinant parvovirus vectors
03/05/2003EP1286695A1 Antigenic composition comprising a polycationic peptide and inosine and cytosine
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286686A2 Methods for preventing strokes by inducing tolerance to e-selectin
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286680A1 Seaweed supplement diet for enhancing immune response in mammals and poultry
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
03/05/2003EP1286664A2 Method of treating immune pathologies with low dose estrogen
03/05/2003EP1286657A1 Nasal ointment based on white petroleum jelly
03/05/2003EP1286609A1 Chair
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1069907A4 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
03/05/2003EP1026167B1 Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0964865B1 Pharmaceutically active tricyclic amines
03/05/2003EP0928197B1 Use of proteins as agents against autoimmune diseases
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0874851B1 Macrocyclic compounds made from carbon suboxide units
03/05/2003EP0782441B1 Pharmaceutical control of inflammation
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400909A Pharmaceutical composition
03/05/2003CN1400903A Novel combination of non sedative anti histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis
03/05/2003CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the
03/05/2003CN1400870A Improved pediatric formula and methods for providing nutrition and improving tolerance
03/05/2003CN1400869A Inulin products with improved nutritional properties
03/05/2003CN1400020A heterogenic chimaera, its preparation method and application
03/05/2003CN1400014A Cordyceps capsule and its preparation method
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102404C Superfine american ginseng capsule and preparation thereof
03/05/2003CN1102403C Huanyang oral liquid
03/05/2003CN1102382C Preparation and methods for the treatment of T cell mediated diseases
03/04/2003US6528699 Inserting nucleic acid construct which comprises promoter, milk protein specific signal sequence; can use for treating diabetes and multiple sclerosis
03/04/2003US6528634 Aiolos gene
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528522 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
03/04/2003US6528514 Pyrimidin-4-one-5-amino-3-alkylcarboxamidomethyl compounds
03/04/2003US6528512 Cytokine specific binding protein;
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528482 Receptor activator of NF-κB
03/04/2003US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528058 Saponin adjuvant composition
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
02/2003
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof
02/27/2003WO2003016563A2 Novel molecular target for neurotoxicity
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes
02/27/2003WO2003016506A2 Secreted proteins
02/27/2003WO2003016493A2 Transporters and ion channels
02/27/2003WO2003016472A2 Hybrid interferon/interferon tau proteins, compositions and methods of use
02/27/2003WO2003016469A2 Chemo-enzymatic synthesis of sialylated oligosaccharides
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016350A1 A method of producing antibodies ex-vivo
02/27/2003WO2003016346A1 Ligands
02/27/2003WO2003016340A1 Derp1 and proderp1 allergen derivatives
02/27/2003WO2003016335A2 Irreversible cysteine protease inhibitors of legumain
02/27/2003WO2003016326A1 Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
02/27/2003WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003WO2003016279A1 Fused-polycyclic compounds
02/27/2003WO2003016269A1 5-amidino-n-(2-aminophenethyl)-n-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2003016248A2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
02/27/2003WO2003015828A1 Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2h-pryrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea and a cyclodextrin
02/27/2003WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b
02/27/2003WO2003015816A1 Immunomodulatory oligonucleotide formulations and methods for use thereof
02/27/2003WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
1 ... 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 ... 1172